Home Company Team Technology Products Investors Contact Us
Team

Management Team

Board of Directors

Scientific Advisory Board
 
Management Team

Thomas J. Meade, Ph.D., Founder, is the Eileen M. Foell Professor of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology and Radiology at Northwestern University. He has founded three successful start-up companies based on his research at the California Institute of Technology and Northwestern University: Clinical Micro Sensors (CMS) now Genmark Diagnostics, which is developing electrochemical sensors for the detection of nucleic acids, Metaprobe, which has focused on in vivo biochemically-activated magnetic resonance contrast agents, and PreDx, a company also focused on imaging technologies. CMS was acquired by Motorola in 2000 for $300 million. Dr. Meade is currently the inventor on more than 70 patents and patent applications, including ones that Ohmx has licensed from CMS and Northwestern University.

Charles Pennington, President & CEO. Prior to joining Ohmx, Charles was the President of TechLab, Inc., a manufacturer of medical diagnostics products targeted at intestinal diseases. He has over 30 years of experience in the design, development and commercialization of medical diagnostic reagents and instrumentation systems. Charles also served as the Director of Life Sciences at Luna Innovations, Director of Product Development at Luna Analytics and held various positions during his 15 years at Abbott Diagnostics. Charles obtained his M.S. in Biochemistry and MBA from Virginia Tech and a B.S. Degree in Biology from the University of Akron.

Barbara B. Dyson, Chairman of the Board of Directors, is a Founder and Principal of Dyson, Dyson & Dunn, Inc., a holding company focused on middle market industrial manufacturing, distribution, and service companies. Ms. Dyson's firm owns and operates eight companies with sales of over $200 million. Ms. Dyson received her B.S. in Economics from Rollins College and has an M.B.A. from Northwestern University's Kellogg School of Management. She is currently on the Executive Advisory Board for the Chemistry of Life Processes Institute at Northwestern University.

Paul Bao, Ph.D., VP of Product Development, joined Ohmx in 2011 with over 18 years of experience in the IVD industry. From 2002 to 2011, he was Sr. Manager and the Head of Assay Research at Nanosphere Inc., a nanotechnology-based diagnostics company. At Nanosphere Inc. Paul   led a team developing multiple ultra-sensitive protein and DNA assays, including an SNP assay in un-amplified human genomic DNA, which was the first FDA 510(k) cleared genetic test based on nanotechnology. Paul was previously a Manager in the Biochemistry Department, at Corning Inc., working on developing microarray bioassays.  Prior to Corning he was a Sr. Scientist at Vysis (now part of Abbott Laboratories), where he was responsible for the development of a microarray based CGH assays for detecting genetic diseases and cancers. Paul was a Postdoctoral Research Fellow at Dupont-Merck Pharmaceutical where he focused on probe design and ligand-binding assay for drug discovery. Paul holds a Ph.D. in Biochemistry/Molecular Biology from the University of Texas at Austin, a M.S. in Biology from Virginia Tech., and a B.S. in Biology from the Zhejiang University, PRC.

Grace Kefer, CPA, Acting Controller, brings to Ohmx over twenty years of experience of financial and administrative management in various industries and also serves as the CEO of Kefer Business Solutions.  A former graduate of Northern Illinois University, Grace took her knowledge and experience from auditing entrepreneurial companies in the public accounting sector, and consulted with clients in the middle market from start-up through sales and acquisition.  Grace was previously with Price Waterhouse and Arthur Anderson and she is currently Acting Controller of Ohmx, overseeing the accounting, administrative and personnel branches.

.

 

[ back to top ]

 

Design by Digizyme